<DOC>
	<DOCNO>NCT02006810</DOCNO>
	<brief_summary>The main objective develop validate new endothelial function marker discriminate reproducible assess ability reveal change endothelial function response positive negative nutritional stimulus .</brief_summary>
	<brief_title>Development Endothelial Biomarkers</brief_title>
	<detailed_description>The study randomize ( order take product : single dose lipid single dose flavonoid ) , single-blinded , cross-over population ( healthy metabolic syndrome ) .</detailed_description>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>40 65 year old male nonsmoker Specific inclusion criterion healthy subject : Healthy subject take antihypertensive statin . Healthy subject present metabolic syndrome one criterion metabolic syndrome tolerate . Specific inclusion criterion subject metabolic syndrome : subject metabolic syndrome must least 3 5 criterion associate metabolic syndrome . treatment vasodilator nitric oxide liberate , diabetes coronary artery disease , chronic alcoholism , severe hepatic impairment , end stage renal failure dialysis , neurological tremor , cancer , mental illness severe disease impact inform consent / result , Refusal register National File Volunteers Person exclusion National Volunteer File</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Endothelium biomarkers</keyword>
	<keyword>Atherosclerotic disease</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>Nutritional stimulus</keyword>
</DOC>